These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 33815095)

  • 21. Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research.
    Bimonte S; Crispo A; Amore A; Celentano E; Cuomo A; Cascella M
    In Vivo; 2020 Jun; 34(3 Suppl):1597-1602. PubMed ID: 32503817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19).
    Shah S; Das S; Jain A; Misra DP; Negi VS
    Int J Rheum Dis; 2020 May; 23(5):613-619. PubMed ID: 32281213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19.
    Kumar P; Sah AK; Tripathi G; Kashyap A; Tripathi A; Rao R; Mishra PC; Mallick K; Husain A; Kashyap MK
    Mol Cell Biochem; 2021 Feb; 476(2):553-574. PubMed ID: 33029696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. State-of-the-art Tools to Elucidate the Therapeutic Potential of TAT-peptide (TP) Conjugated Repurposing Drug Against SARS-CoV-2 Spike Glycoproteins.
    Ansari MA; Alomary MN; Jamal QMS; Almoshari Y; Salawi A; Almahmoud SA; Khan J
    Curr Pharm Des; 2022; 28(46):3706-3719. PubMed ID: 36278465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines.
    Awadasseid A; Wu Y; Tanaka Y; Zhang W
    Biomed Pharmacother; 2021 May; 137():111330. PubMed ID: 33550043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathophysiology and Potential Therapeutic Candidates for COVID-19: A Poorly Understood Arena.
    Samaddar A; Grover M; Nag VL
    Front Pharmacol; 2020; 11():585888. PubMed ID: 33041830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.
    Sanders JM; Monogue ML; Jodlowski TZ; Cutrell JB
    JAMA; 2020 May; 323(18):1824-1836. PubMed ID: 32282022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment.
    Drożdżal S; Rosik J; Lechowicz K; Machaj F; Szostak B; Przybyciński J; Lorzadeh S; Kotfis K; Ghavami S; Łos MJ
    Drug Resist Updat; 2021 Dec; 59():100794. PubMed ID: 34991982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Review on Current Repurposing Drugs for the Treatment of COVID-19: Reality and Challenges.
    Hossen MS; Barek MA; Jahan N; Safiqul Islam M
    SN Compr Clin Med; 2020; 2(10):1777-1789. PubMed ID: 32904710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological and non-pharmacological efforts at prevention, mitigation, and treatment for COVID-19.
    Alvi MM; Sivasankaran S; Singh M
    J Drug Target; 2020; 28(7-8):742-754. PubMed ID: 32643436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small-molecule Antiviral Agents in Ongoing Clinical Trials for COVID-19.
    Apaydın ÇB; Çınar G; Cihan-Üstündağ G
    Curr Drug Targets; 2021; 22(17):1986-2005. PubMed ID: 33588727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging Therapeutic Approaches to Combat COVID-19: Present Status and Future Perspectives.
    Vivekanandhan K; Shanmugam P; Barabadi H; Arumugam V; Daniel Raj Daniel Paul Raj D; Sivasubramanian M; Ramasamy S; Anand K; Boomi P; Chandrasekaran B; Arokiyaraj S; Saravanan M
    Front Mol Biosci; 2021; 8():604447. PubMed ID: 33763450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies.
    Gong W; Parkkila S; Wu X; Aspatwar A
    Int Rev Immunol; 2023; 42(6):393-414. PubMed ID: 35635216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic approaches and potential therapeutic options for coronavirus disease 2019.
    Khan Z; Ghafoor D; Khan A; Ualiyeva D; Khan SA; Bilal H; Khan B; Khan A; Sajjad W
    New Microbes New Infect; 2020 Nov; 38():100770. PubMed ID: 33014380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antivirals and the Potential Benefits of Orally Inhaled Drug Administration in COVID-19 Treatment.
    Sahin G; Akbal-Dagistan O; Culha M; Erturk A; Basarir NS; Sancar S; Yildiz-Pekoz A
    J Pharm Sci; 2022 Oct; 111(10):2652-2661. PubMed ID: 35691607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial.
    Brown LK; Freemantle N; Breuer J; Dehbi HM; Chowdhury K; Jones G; Ikeji F; Ndoutoumou A; Santhirakumar K; Longley N; Checkley AM; Standing JF; Lowe DM
    Trials; 2021 Mar; 22(1):193. PubMed ID: 33685502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions.
    Khan WH; Hashmi Z; Goel A; Ahmad R; Gupta K; Khan N; Alam I; Ahmed F; Ansari MA
    Front Cell Infect Microbiol; 2021; 11():690621. PubMed ID: 34568087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic Effectiveness and Safety of Repurposing Drugs for the Treatment of COVID-19: Position Standing in 2021.
    Alam S; Kamal TB; Sarker MMR; Zhou JR; Rahman SMA; Mohamed IN
    Front Pharmacol; 2021; 12():659577. PubMed ID: 34220503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics.
    Wang D; Li Z; Liu Y
    J Infect Public Health; 2020 Oct; 13(10):1405-1414. PubMed ID: 32684351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.